1. Circulating tumor cells in colorectal cancer in the era of precision medicine
- Author
-
Zeen Wu, Chungen Xing, Qiang Wang, Mingchao Hu, Renjun Pei, Zhili Wang, and Pi Ding
- Subjects
Oncology ,medicine.medical_specialty ,Colorectal cancer ,Review ,Metastasis ,Circulating Tumor DNA ,Circulating tumor cell ,Carcinoembryonic antigen ,Internal medicine ,Drug Discovery ,Biopsy ,medicine ,Animals ,Humans ,Genetics (clinical) ,medicine.diagnostic_test ,biology ,business.industry ,Precision medicine ,Circulating tumor cells ,Cancer ,medicine.disease ,Neoplastic Cells, Circulating ,Primary tumor ,digestive system diseases ,biology.protein ,Molecular Medicine ,business ,Colorectal Neoplasms ,Biomarkers - Abstract
Colorectal cancer (CRC) is one of the main causes of cancer-related morbidity and mortality across the globe. Although serum biomarkers such as carcinoembryonic antigen (CEA) and carbohydrate antigen 19–9 (CA-199) have been prevalently used as biomarkers in various cancers, they are neither very sensitive nor highly specific. Repeated tissue biopsies at different times of the disease can be uncomfortable for cancer patients. Additionally, the existence of tumor heterogeneity and the results of local biopsy provide limited information about the overall tumor biology. Against this backdrop, it is necessary to look for reliable and noninvasive biomarkers of CRC. Circulating tumor cells (CTCs), which depart from a primary tumor, enter the bloodstream, and imitate metastasis, have a great potential for precision medicine in patients with CRC. Various efficient CTC isolation platforms have been developed to capture and identify CTCs. The count of CTCs, as well as their biological characteristics and genomic heterogeneity, can be used for the early diagnosis, prognosis, and prediction of treatment response in CRC. This study reviewed the existing CTC isolation techniques and their applications in the clinical diagnosis and treatment of CRC. The study also presented their limitations and provided future research directions.
- Published
- 2021